IP Library Patent Application 12046243
Patent Application
App. No. 12/046,243

METHODS FOR PRODUCING HUMAN ANTIBODIES IN SCID MICE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/046,243
Abstract

An improved method for producing human antibodies in SCID mice is provided. The improvement includes the use of dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agents.

Claims (13)

1 . A method for producing human antibodies in SCID mice which comprises immunizing SCID mice with dendritic cells which have been contacted (pulsed) in vitro with an antigen-antibody complex.

2 . The method of claim 1 , wherein the antigen is prostrate specific antigen.

3 . The method of claim 2 , wherein the antibody is a mouse IgG 2a antibody.

4 . The method of claim 1 , wherein the dendritic cells comprise autologous peripheral blood dendritic cells.

5 . The method of claim 1 , which includes EBV transformation during the immunization step.

6 . The method of claim 1 , wherein the antibody is anti-PSA IgG 2a monoclonal antibody and the antigen is PSA.

7 . The method of claim 1 , wherein said SCID mice are immunized with antigen-antibody complex prior to a immunization with dendritic which have been contacted (pulsed) with antigen-antibody complex.

8 . The method of claim 1 , wherein the second immunization is effected about 1 to 15 days after the first.

9 . The method of claim 8 , wherein said second immunization is effected about 7 days after the first immunization.

10 . The method of claim 7 , which further includes at least one additional immunization (“boosting”) wherein SCID mice is administered antigen or antigen-antibody complex.

11 . The method of claim 10 , wherein a boosting step is effected about a week after the first immunization.

12 . The method of claim 11 , wherein another boosting step is effected about two weeks after the first immunization.

13 . The method of claim 12 , wherein another boosting step is effected about three weeks after the first immunization.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2008
From: COCCIA, MARCO ANTHONY; BRAMS, PETER
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 021886/0060 →
CHANGE OF NAME Recorded Nov 25, 2008
From: IDEC PHARMACEUTICALS CORPORATION
To: BIOGEN IDEC INC.
Reel/Frame 021886/0784 →